Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vivani Medical, Inc.

1.15
+0.01000.88%
Volume:64.58K
Turnover:74.11K
Market Cap:68.13M
PE:-2.75
High:1.16
Open:1.13
Low:1.13
Close:1.14
Loading ...

Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register Now

GlobeNewswire
·
26 Mar

Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025

Business Wire
·
24 Mar

What Makes Vivani Medical (VANI) a New Buy Stock

Zacks
·
18 Mar

Vivani Medical Completes Enrollment, Begins Dosing in Diabetes Implant Trial

MT Newswires Live
·
13 Mar

Vivani Medical announces 1st GLP-1 implant in Liberate-1 clinical trial

TIPRANKS
·
13 Mar

BRIEF-Vivani Medical Achieves First Implant And Full Enrollment In The First-In-Human Clinical Trial Of GLP-1 Implant NPM-115 In Obese Or Overweight Adults

Reuters
·
13 Mar

Vivani Medical Inc: Npm-115 Has Showed Comparable Preclinical Weight Loss to Injections of Semaglutide

THOMSON REUTERS
·
13 Mar

Vivani Medical Inc - Top-Line Study Results Expected in Mid-2025

THOMSON REUTERS
·
13 Mar

Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of Glp-1 Implant Npm-115 in Obese or Overweight Adults

THOMSON REUTERS
·
13 Mar

Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults

Business Wire
·
13 Mar

EXCLUSIVE: Vivani Medical Announces First Implant In Early-Stage Human Study Of GLP-1 Implant For Obesity

Benzinga
·
13 Mar

Vivani Medical Price Target Maintained With a $4.00/Share by HC Wainwright & Co.

Dow Jones
·
13 Mar

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Vivani Medical (VANI) and Merit Medical Systems (MMSI)

TIPRANKS
·
21 Dec 2024

Vivani reports start of first human trial of GLP-1 implant, says H.C. Wainwright

TIPRANKS
·
21 Dec 2024